Trials / Recruiting
RecruitingNCT07343115
Familial Systemic Scleroderma
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Studying familial forms of systemic scleroderma offers several advantages: 1. To better understand the pathophysiology of a complex autoimmune disease based on "extreme" cases (familial forms); 2. To identify potential molecular markers predictive of disease progression; 3. To identify potential pathophysiological targets for developing new therapies, particularly relevant in severe and refractory forms of the disease.
Conditions
Timeline
- Start date
- 2025-09-02
- Primary completion
- 2026-09-01
- Completion
- 2026-09-02
- First posted
- 2026-01-15
- Last updated
- 2026-01-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT07343115. Inclusion in this directory is not an endorsement.